Stourbridge, United Kingdom

Rosella Kendrick

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Kci Licensing, Inc., Kci Manufacturing Unlimited Company. Active years: 2018-2026.


% Patents Active = 66.7


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rosella Kendrick: Innovator in Tissue Treatment Technologies

Introduction

Rosella Kendrick is a notable inventor based in Stourbridge, GB. She has made significant contributions to the field of tissue treatment technologies, holding 3 patents that showcase her innovative approach to managing hair proximate to tissue sites.

Latest Patents

Kendrick's latest patents focus on systems, methods, and devices for treating a tissue site on a mammal that has hair nearby. These inventions provide compositions designed to inhibit, remove, or weaken hair around the tissue site while ensuring an improved fluid seal through a flexible film drape. The hair-modification agent is strategically placed to flow over imperfections on the epidermis, forming a fluid seal and effectively weakening hair as it encounters the agent.

Career Highlights

Throughout her career, Kendrick has worked with reputable companies such as KCI Licensing, Inc. and KCI Manufacturing Unlimited Company. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in medical technologies.

Collaborations

Kendrick has collaborated with professionals like Timothy Mark Robinson and Elliott James Rider, further enhancing her innovative projects and expanding her impact in the field.

Conclusion

Rosella Kendrick's work in tissue treatment technologies exemplifies her dedication to innovation and improvement in medical practices. Her patents reflect a commitment to enhancing patient care through effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…